Mesa Laboratories (MLAB) Cash from Financing Activities (2010 - 2026)

Mesa Laboratories has reported Cash from Financing Activities for 16 years, with the latest figure at -$9.8 million in Q4 2025.

• Quarterly Cash from Financing Activities rose 4.88% year-over-year to -$9.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$42.3 million (down 2.52% YoY) and the FY2025 annual result came in at -$44.5 million, down 235.55% from the prior year.
• Cash from Financing Activities declined to -$9.8 million in Q4 2025 per MLAB's latest filing, from -$7.9 million in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $61.2 million in Q4 2021 and troughed at -$18.6 million in Q3 2022.
• A 5-year average of -$978350.0 and a median of -$8.5 million in 2024 frame the typical range for Cash from Financing Activities.
• The sharpest annual moves came in 2021 and 2022: Cash from Financing Activities soared 35689.47% in 2021, then tumbled 1710.19% in 2022.
• Over 5 years, Cash from Financing Activities stood at $61.2 million in 2021, then tumbled by 114.51% to -$8.9 million in 2022, then soared by 784.99% to $60.8 million in 2023, then tumbled by 116.91% to -$10.3 million in 2024, then grew by 4.88% to -$9.8 million in 2025.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered -$9.8 million, -$7.9 million, and -$8.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.